June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Microglia Activation and Polarization Associated with Retinal Inflammation and Degeneration in rd1 mouse model
Author Affiliations & Notes
  • Tian Zhou
    Zhongshan Ophthalmic Center, Sun Yat-Sen University , Guangzhou, Guangdong, China
  • Chang He
    Zhongshan Ophthalmic Center, Sun Yat-Sen University , Guangzhou, Guangdong, China
  • Zijing Huang
    Zhongshan Ophthalmic Center, Sun Yat-Sen University , Guangzhou, Guangdong, China
  • Xiaowei Sun
    Zhongshan Ophthalmic Center, Sun Yat-Sen University , Guangzhou, Guangdong, China
  • Xialin Liu
    Zhongshan Ophthalmic Center, Sun Yat-Sen University , Guangzhou, Guangdong, China
  • Footnotes
    Commercial Relationships   Tian Zhou, None; Chang He, None; Zijing Huang, None; Xiaowei Sun, None; Xialin Liu, None
  • Footnotes
    Support  National Natural Science Foundation of China (No. 81630022)
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 5400. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Tian Zhou, Chang He, Zijing Huang, Xiaowei Sun, Xialin Liu; Microglia Activation and Polarization Associated with Retinal Inflammation and Degeneration in rd1 mouse model. Invest. Ophthalmol. Vis. Sci. 2017;58(8):5400.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Microglia has been recognized to be a special type of immune cells in retina. However, the role and mechanism of microglia in retinal degeneration disease are poorly understood. This study was to explore the activation and phenotype of microglia in rd1 mice, a widely used animal model of retinitis pigmentosa.

Methods : Rd1 (Pde6brd1/rd1) mice were used for study with wild-type C57BL/6 mice of the same ages as controls. Retinal degeneration condition were observed by the fundus imaging, ERG and OCT. Eyeballs and retina of rd1 mice at different postnatal days (P7, P14, P21, P28, P56 and P180) were collected and prepared for cryosections, whole mount, retinal cells and cell lysate. The microglia maker Iba-1, activation marker CD68 and CX3CR1, and phenotype markers CD86, CD206 and CD16/32, as well as pro-inflammatory cytokines were evaluated by immunofluorescent staining, flow cytometry, RT-qPCR, ELISA and Western blot analysis.

Results : The retinal degeneration was observed at early age of P7, developed progressively with thinner retina at P14 and P21, and lost most photoreceptors at P28 in rd1 mice when compared with C57 mice. The expression of CD68 and CX3CR1 increased significantly with ages at P7, P14, P21 and P28 in rd1 retinae, indicating microglia activation at the acute stage. Morphologically, activated microglia was characterized by round shape with short dendrites in rd1 mice. The number of microglia increased significantly by ages with the peak levels at p14. Flow cytometry revealed that the percentage of CD86+CD206- microglia (M1 phenotype) increased markedly during P14 to P28 in rd1 retinae compared to C57 mice. The CD16/32+ (M1 marker) microglia was immune-localized mainly in ONL at P14 while in INL at P28, suggesting potential migration to the degeneration area. Furthermore, RT-qPCR revealed the higher expression of pro-inflammatory cytokines (TNF-a, IL-6 and CCL2) in rd1 mice than C57 mice.

Conclusions : Our findings uncover a novel mechanism that microglia is activated and polarized to M1 phenotype that is associated with stimulated pro-inflammatory cytokines during retinal degenerative process in rd1 mice. This study sheds lights on pathogenesis of retinal regeneration disease, and may provide novel targets for therapeutic potential.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×